Advertisement
A key focus is characterizing arteriopathy, a prime predictor of recurrence
Executive function, social roles and physical function loom large in new study
Phase 3 EXPAND trial suggests potential utility of siponimod
Novel monoclonal antibody takes aim at alpha-synuclein clusters
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic offers an abundance of direct delivery trials
Most substantial reversal of amyloid deposition in an animal study to date
Door-to-needle time improved by 26 percent from 2014 to 2017
First study of this question supports prioritizing speed in ELVO cases
CSCs achieve timelier acute reperfusion therapy, national study finds
DEFUSE 3 results support lengthening treatment window in imaging-selected patients
Advertisement
Advertisement